TBPH news

Latest 1 stories · newest Aug 10, 2026

TBPH

Theravance Biopharma Announces Strategic Sale to Zymeworks

Theravance Biopharma reported second quarter 2026 financials with cost reductions and cash update ahead of an acquisition by Zymeworks. The deal is expected to deliver significant value for shareholders as the company balances organic execution with its exit strategy.

M&A Aug 10, 2026 sentiment +1.00 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same TBPH feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/TBPH/newsSTART FREE